Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Simoons

Showing results (271-280 of 338) with videos related to

Pageof 34
Sort By:
The American Journal of Cardiology|November 17, 1998
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary interventionD L Bhatt, A M Lincoff, D J Kereiakes, et al.
International Journal of Cardiology|July 1, 1985
Left ventricular performance in unstable angina: assessment with radionuclide techniquesE E van der Wall, H J Kerkkamp, J Lubsen, et al.
Lancet (London, England)|January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialD R Holmes, R M Califf, F Van de Werf, et al.
European Heart Journal|September 7, 2000
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind studyE Ronner, H A van Kesteren, P Zijnen, et al.
European Heart Journal|July 22, 1999
Minimal myocardial damage during coronary intervention is associated with impaired outcomeM L Simoons, M van den Brand, M Lincoff, et al.
The New England Journal of Medicine|May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarctionD B Mark, M A Hlatky, R M Califf, et al.
The American Journal of Cardiology|January 1, 1987
Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology InstituteF W Bar, F Vermeer, C de Zwaan, et al.
Transplantation Proceedings|February 1, 1987
Circadian variation of heart rate but not of blood pressure after heart transplantationG J Wenting, A H vd Meiracker, M L Simoons, et al.
American Heart Journal|October 1, 1986
Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarctionA van der Laarse, F Vermeer, W T Hermens, et al.
American Heart Journal|September 1, 1999
Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trialK G Moons, P Klootwijk, S H Meij, et al.
Pageof 34

Showing results (271-280 of 338) with videos related to

Sort By:
Pageof 34
The American Journal of Cardiology|November 17, 1998
Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary interventionD L Bhatt, A M Lincoff, D J Kereiakes, et al.
International Journal of Cardiology|July 1, 1985
Left ventricular performance in unstable angina: assessment with radionuclide techniquesE E van der Wall, H J Kerkkamp, J Lubsen, et al.
Lancet (London, England)|January 11, 1997
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trialD R Holmes, R M Califf, F Van de Werf, et al.
European Heart Journal|September 7, 2000
Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction; a phase II dose escalation, randomized, double-blind studyE Ronner, H A van Kesteren, P Zijnen, et al.
European Heart Journal|July 22, 1999
Minimal myocardial damage during coronary intervention is associated with impaired outcomeM L Simoons, M van den Brand, M Lincoff, et al.
The New England Journal of Medicine|May 25, 1995
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarctionD B Mark, M A Hlatky, R M Califf, et al.
The American Journal of Cardiology|January 1, 1987
Value of admission electrocardiogram in predicting outcome of thrombolytic therapy in acute myocardial infarction. A randomized trial conducted by The Netherlands Interuniversity Cardiology InstituteF W Bar, F Vermeer, C de Zwaan, et al.
Transplantation Proceedings|February 1, 1987
Circadian variation of heart rate but not of blood pressure after heart transplantationG J Wenting, A H vd Meiracker, M L Simoons, et al.
American Heart Journal|October 1, 1986
Effects of early intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomized trial of 533 patients with acute myocardial infarctionA van der Laarse, F Vermeer, W T Hermens, et al.
American Heart Journal|September 1, 1999
Continuous ST-segment monitoring associated with infarct size and left ventricular function in the GUSTO-I trialK G Moons, P Klootwijk, S H Meij, et al.
Pageof 34